N4-(4-Fluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity), 97%, 50mg

(R)-3-Amino-4-(tert-butoxy)butanoic acid, 95.0%, 250mg

[2-chloro-5-(trifluoromethyl)phenyl]hydrazine hydrochloride, 97%, 5g

3-Phenyl-propionic acid hydrazide, 95.0%, 5g

3,4-Dimethylphenoxyacetic acid, 98.0%, 50g

(R)-3-((tert-Butoxycarbonyl)amino)-3-cyclohexylpropanoic acid, 1g

2-((3,5-Difluoro-4-hydroxyphenyl)amino)-8-isopentyl-5,7-dimethyl-7,8-dihydropteridin-6(5H)-one, 95.0%, 50mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(2,3-dihydro-1H-inden-2-yl)acetic acid, 95%, 1g

2-METHANESULFONYL-2-METHYLPROPANENITRILE, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(pyridin-3-yl)phenyl)propanoic acid, 97%, 100mg

Closure clips Spectra/Por® Standard caps, 35 mm, 10 Piece(s)

Methyl 4-oxotetrahydro-2H-pyran-3-carboxylate, 95.0%, 1g

1-adamantylmethanol, 98.0%, 25g